Patterns of Use and Discontinuation of Secondary Prevention Medications After Stroke
OBJECTIVETo investigate whether certain patient, acute-care, or primary-care factors are associated with medication initiation and discontinuation in the community post-stroke or TIA. METHODSRetrospective cohort study using prospective data on adult patients with first-ever acute stroke/TIA from the...
Gespeichert in:
Veröffentlicht in: | Neurology 2021-01, Vol.96 (1), p.e30-e41 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVETo investigate whether certain patient, acute-care, or primary-care factors are associated with medication initiation and discontinuation in the community post-stroke or TIA.
METHODSRetrospective cohort study using prospective data on adult patients with first-ever acute stroke/TIA from the Australian Stroke Clinical Registry (April 2010 to June 2014), linked with nationwide medication dispensing and Medicare claims data. Medication users were those with ≥1 dispensing in the year post-discharge. Discontinuation was assessed among medication users and defined as having no medication supply for ≥90 days in the year post-discharge. Multivariable competing risks regression, accounting for death during the observation period, was conducted to investigate factors associated with time to medication discontinuation.
RESULTSAmong 17,980 registry patients with stroke/TIA, 91.4% were linked to administrative datasets. Of these, 9,817 adults with first-ever stroke/TIA were included (45.4% female, 47.6% aged ≥75 years, and 11.4% intracerebral hemorrhage). While most patients received secondary prevention medications (79.3% antihypertensive, 81.8% antithrombotic, and 82.7% lipid-lowering medication), between one-fifth and one-third discontinued treatment over the subsequent year post-discharge (20.9% antihypertensive, 34.1% antithrombotic, and 28.5% lipid-lowering medications). Prescription at hospital discharge (sub-hazard ratio [SHR]0.70; 95% CI0.62–0.79), quarterly contact with a primary-care physician (SHR0.62; 95% CI0.57–0.67), and prescription by a specialist physician (SHR0.87; 95% CI0.77–0.98) were all inversely associated with antihypertensive discontinuation.
CONCLUSIONSPatterns of use of secondary prevention medications after stroke/TIA are not optimal, with many survivors discontinuing treatment within one-year post-discharge. Improving post-discharge care for patients with stroke/TIA is needed to minimize unwarranted discontinuation. |
---|---|
ISSN: | 0028-3878 1526-632X |
DOI: | 10.1212/WNL.0000000000011083 |